Efficacy and Safety of Upadacitinib Treatment in Adolescents with Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials

Amy S. Paller*, Barry Ladizinski, Pedro Mendes-Bastos, Elaine Siegfried, Weily Soong, Vimal H. Prajapati, Peter Lio, Jacob P. Thyssen, Eric L. Simpson, Andrew M. Platt, Eliza M. Raymundo, Jianzhong Liu, Brian M. Calimlim, Xiaohong Huang, Yihua Gu, Xiaofei Hu, Yang Yang, John C. Su, Min Zheng, Kiwako Yamamoto-HanadaHenrique D. Teixeira, Alan D. Irvine

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Upadacitinib Treatment in Adolescents with Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Nursing and Health Professions